These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35644501)

  • 1. Trends and Outcomes of ST-Segment-Elevation MI in Hospitalized Patients Without Standard Modifiable Cardiovascular Risk Factors.
    Shrestha B; Mochon A; Poudel B; Poudel D; Donato A
    Curr Probl Cardiol; 2022 Sep; 47(9):101271. PubMed ID: 35644501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of ST Segment Elevation Myocardial Infarction without Standard Modifiable Cardiovascular Risk Factors - Newer Insights from a Prospective Registry in India.
    Justin Paul G; Sankaran S; Saminathan K; Iliyas M; Sethupathy S; Saravanan S; Prabhu SS; Kurian S; Srinivas S; Anurag P; Srinivasan K; Manimegalai E; Nagarajan S; Ramesh R; Nageswaran PM; Sangareddi V; Govindarajulu R
    Glob Heart; 2023; 18(1):13. PubMed ID: 36936250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard modifiable cardiovascular risk factors in patients with acute coronary syndrome: A report from multicenter percutaneous coronary intervention registry.
    Iwata J; Inohara T; Shiraishi Y; Nakamaru R; Niimi N; Ueda I; Suzuki M; Noma S; Numasawa Y; Fukuda K; Kohsaka S
    J Cardiol; 2023 Jun; 81(6):571-576. PubMed ID: 36758671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Nicholls SJ; Chow CK; Psaltis P; Røsjø H; Leósdóttir M; Hagström E
    J Am Heart Assoc; 2022 Aug; 11(15):e024818. PubMed ID: 35876409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Hospital Outcomes of ST-Segment Elevation Myocardial Infarction Complicated With Cardiogenic Shock at Safety-Net Hospitals in the United States (from the Nationwide Inpatient Sample).
    Ando T; Akintoye E; Adegbala O; Ashraf S; Shokr M; Takagi H; Grines CL; Afonso L; Briasoulis A
    Am J Cardiol; 2019 Aug; 124(4):485-490. PubMed ID: 31213279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic Disparities in ST-Segment Elevation Myocardial Infarction Outcomes and Processes of Care in Patients With and Without Standard Modifiable Cardiovascular Risk Factors: A Nationwide Cohort Study.
    Weight N; Moledina S; Sun L; Kragholm K; Freeman P; Diaz-Arocutipa C; Dafaalla M; Gulati M; Mamas MA
    Angiology; 2023 Jun; ():33197231182555. PubMed ID: 37306087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of ST elevation myocardial infarction patients without standard modifiable risk factors.
    Singh YS; Wada H; Ogita M; Takamura Y; Onozato T; Fujita W; Abe K; Shitara J; Endo H; Tsuboi S; Suwa S; Miyauchi K; Minamino T
    J Cardiol; 2024 Jul; 84(1):41-46. PubMed ID: 38043707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors.
    Vernon ST; Coffey S; Bhindi R; Soo Hoo SY; Nelson GI; Ward MR; Hansen PS; Asrress KN; Chow CK; Celermajer DS; O'Sullivan JF; Figtree GA
    Eur J Prev Cardiol; 2017 Nov; 24(17):1824-1830. PubMed ID: 28703626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention.
    Amon J; Wong GC; Lee T; Singer J; Cairns J; Shavadia JS; Granger C; Gin K; Wang TY; van Diepen S; Fordyce CB
    J Am Heart Assoc; 2022 Sep; 11(17):e025572. PubMed ID: 36056738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?
    Vernon ST; Coffey S; D'Souza M; Chow CK; Kilian J; Hyun K; Shaw JA; Adams M; Roberts-Thomson P; Brieger D; Figtree GA
    J Am Heart Assoc; 2019 Nov; 8(21):e013296. PubMed ID: 31672080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry.
    Li S; Gao X; Yang J; Xu H; Wang Y; Zhao Y; Yin L; Wu C; Wang Y; Zheng Y; Li B; Zhang X; Ye Y; Fu R; Dong Q; Sun H; Yan X; Wu Y; Zhang J; Jin C; Li W; Yang Y;
    BMC Med; 2022 Jul; 20(1):217. PubMed ID: 35790971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality of patients presented with acute ST-segment elevation myocardial infarction according to the status of standard modifiable cardiovascular risk factors.
    Glądys K; Siudak Z; Trzeciak P; Siłka W; Skrzypek M; Chyrchel M; Gąsior M; Januszek R
    Am J Med Sci; 2024 May; 367(5):328-336. PubMed ID: 38320673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors-A DANAMI-3 substudy.
    Mazhar J; Ekström K; Kozor R; Grieve SM; Nepper-Christensen L; Ahtarovski KA; Kelbæk H; Høfsten DE; Køber L; Vejlstrup N; Vernon ST; Engstrøm T; Lønborg J; Figtree GA
    Front Cardiovasc Med; 2022; 9():945815. PubMed ID: 35990971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, management, and 5-year survival compared between no standard modifiable risk factor (SMuRFless) and ≥ 1 SMuRF ACS cases: an analysis of 15,051 cases from Pakistan.
    Sheikh S; Peerwani G; Hanif B; Virani S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):320. PubMed ID: 37355597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Outcomes of Young Patients With ST-Elevation Myocardial Infarction Without Standard Modifiable Risk Factors.
    Kelly C; Lan NSR; Phan J; Hng C; Matthews A; Rankin JM; Schultz CJ; Hillis GS; Reid CM; Dwivedi G; Figtree GA; Ihdayhid AR
    Am J Cardiol; 2023 Sep; 202():81-89. PubMed ID: 37423175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Hospital cardiac arrest complicating ST-elevation myocardial Infarction: Temporal trends and outcomes based on management strategy.
    Bhat AG; Verghese D; Harsha Patlolla S; Truesdell AG; Batchelor WB; Henry TD; Cubeddu RJ; Budoff M; Bui Q; Matthew Belford P; X Zhao D; Vallabhajosyula S
    Resuscitation; 2023 May; 186():109747. PubMed ID: 36822461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.
    Figtree GA; Redfors B; Kozor R; Vernon ST; Grieve SM; Mazhar J; Thiele H; Patel MR; Udelson JE; Selker HP; Ohman EM; Maehara A; Karmpaliotis D; Eitel I; Granger CB; Ben-Yehuda O; Stone GW; Kosmidou I
    JACC Cardiovasc Interv; 2022 Jun; 15(11):1167-1175. PubMed ID: 35680197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial Infarction.
    Gong W; Yan Y; Wang X; Zheng W; Smith SC; Fonarow GC; Morgan L; Liu J; Zhao D; Ma C; Han Y; Montalescot G; Nie S;
    J Am Coll Cardiol; 2022 Nov; 80(19):1788-1798. PubMed ID: 36328690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes for Cancer Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Jacobs JA; Pickworth K; Boudoulas KD; Hinkley M; McLaughlin E; Blais D
    Cardiovasc Revasc Med; 2019 Aug; 20(8):711-715. PubMed ID: 30472243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.